July 16, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools Liq. Handling & Robotics

Promega Maxwell® RNA Extraction System Authorized for Use in CDC COVID-19 Emergency Use Authorization (EUA) Diagnostic Panel

Promega automated sample preparation solution added to CDC COVID-19 test protocol Madison, WI USA. (July 16, 2020) Promega Corporation Maxwell® RSC 48 Instrument and Maxwell® RSC Viral Total Nucleic Acid Purification Kit (Maxwell® Extraction System) are now in the Centers for Disease Control and Prevention’s (CDC) COVID-19 diagnostic protocol for emergency use. In a letter dated July... Read more

April 17, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

Promega successfully completes first fully remote quality surveillance assessment amid COVID-19 restrictions

Biotech manufacturer recommended for continued certification to ISO 9001:2015 and ISO 13485:2016 Madison, WI USA. (April 17, 2020) Promega Corporation announced today it successfully completed its first ever fully remote quality surveillance assessment and is recommended for continued certification to ISO 9001:2015 and ISO 13485:2016. Due to COVID-19 restrictions, the British Standards Institution (BSI) completed its six-day... Read more

April 16, 2020 Clinical Research/Diagn.

Promega to manufacture test kits for Co-Diagnostics’ new coronavirus test

Logix Smart™ COVID-19 Test is authorized for emergency use by the FDA, and CE marked to be sold in Europe Madison, WI USA. (April 16, 2020) Promega Corporation has been contracted by Utah-based Co-Diagnostics, Inc. to support Co-Diagnostics’ efforts to manufacture test kits of its new Logix Smart™ COVID-19 Test. Promega originally provided the custom master mix used... Read more

April 1, 2020 Clinical Research/Diagn. Life Science Tools

Promega GoTaq® Probe 1-Step RT-qPCR System Approved for Use in CDC’s COVID-19 Emergency Use Authorization Diagnostic Panel

Promega amplification reagent added to EUA list for laboratories that follow CDC’s testing protocols Madison, WI USA. (April 1, 2020) Promega Corporation’s GoTaq® Probe 1-Step RT-qPCR System is now in a Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use. The Promega tool is an approved master mix option for the CDC’s 2019-Novel Coronavirus... Read more

March 30, 2020 Clinical Research/Diagn. M&A, Partnerships

Promega Part of New Wisconsin Public-Private Partnership to Increase COVID-19 Laboratory Testing Capacity

Madison, WI USA. (March 30, 2020) Promega Corporation is part of a new public-private partnership among Wisconsin industry leaders to increase the state’s laboratory testing capacity for COVID-19. Wisconsin Governor Tony Evers made the announcement today. The expanded capacity from this new partnership is expected to initially double testing capacity in Wisconsin, currently averaging 1,500-2,000 COVID-19 tests... Read more

February 25, 2020 Clinical Research/Diagn.

Promega Custom Manufacturing Capabilities Aid in Rapid Development of Co-Diagnostics’ New Coronavirus Test

Logix Smart™ COVID-19 Test CE Marked & Available in Europe Four Weeks After Project Initiation Madison, WI USA. (February 25, 2020) Promega Corporation is being recognized by Utah-based Co-Diagnostics, Inc. for the support Promega custom manufacturing provided in the rapid development and launch of the new Logix Smart™ COVID-19 Test. Co-Diagnostics yesterday afternoon announced its coronavirus test received CE mark... Read more

February 24, 2020 Life Science Tools Product Launch

Promega Launches Wizard® HMW DNA Extraction Kit Ahead of 2020 Advances in Genome Biology and Technology (AGBT) Meeting

Madison, WI USA. (February 24, 2020) Promega Corporation a global biotechnology manufacturer, today launched its new Wizard® HMW DNA Extraction Kit for researchers working with large fragments of genomic DNA. The kit, as demonstrated in a poster presented at this week’s 2020 Advances in Genome Biology and Technology (AGBT) meeting, enables researchers to obtain DNA that will provide strong performance in... Read more

November 6, 2019 M&A, Partnerships

Promega Enters Global Collaboration with Merck to Develop Microsatellite Instability (MSI) Companion Diagnostic for Use with KEYTRUDA®

Madison, WI USA. (November 6, 2019) Promega Corporation today announced it has entered into a global collaboration with Merck, known as MSD outside the United States and Canada, to develop Promega’s microsatellite instability (MSI) technology as an on-label, solid tumor companion diagnostic (CDx) for use with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab). The global collaboration will initially... Read more

June 26, 2019 Bio/Pharma/CRO Cell Analysis Tools Life Science Tools

Promega 2019 Corporate Responsibility Report Highlights Commitments to Environmental Sustainability, Employee Well-Being and Community Support

Madison, WI USA. (June 26, 2019) Promega Corporation, a global biotechnology manufacturer, today announced publication of its annual Corporate Responsibility Report of sustainable practices and resulting trends through the previous year. The 2019 report documents how, over the last three years, an overall culture of sustainability resulted in an 8% reduction in the company’s carbon-to-revenue footprint. “We not... Read more

May 31, 2019 Life Science Tools Product Launch

Promega launches Microsatellite Instability (MSI) educational resource in front of 2019 American Society of Clinical Oncology (ASCO) annual meeting

Madison, WI USA. (May 31, 2019) Oncology researchers and clinicians seeking to deepen their understanding of Microsatellite Instability (MSI) have a new resource that gathers a wealth of information in one place, including the importance of MSI as a biomarker and methods of detection. Promega Corporation launched its MSI educational website Promega.com/MSIweb this week ahead of this weekend’s... Read more